CrushSCI.com
154.5Average days
154.5Median days
27Fastest days
323Longest days
1482025 publications

Paper Review Records

All Paper Review Records

22 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

169 days

Impact of ambiguous breast density assessment on mammographic diagnostic performance and comparison with AI-based quantitative density measurement

Authors
Yuna Fukuma; Tsunehisa Nomura; Naruto TairaShow moreShow less
Affiliations
1. Department of Breast and Thyroid Surgery, Kawasaki Medical School, Kurashiki, JapanShow moreShow less
Source PDF DOI Publisher page
222 days

TBK1 as a key regulator in breast cancer: opportunities for targeted therapy

Authors
Helal F. Hetta; Fawaz E. Alanazi; Salwa Qasim Bukhari; Zinab Alatawi; Mashan L. Abdullah; Ali S. Alfardan; Mohammed A. Al-Hamamah; Fahad Abdullah Alshahrani; Fahad O. Alatawi; Tareq Nayef AlRamadneh; Noura H. Abd Ellah; Yasmin N. Ramadan; Ahmed A. KotbShow moreShow less
Affiliations
1. Division of Microbiology, Immunology and Biotechnology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia; 2. Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia; 3. Department of Diagnostic Radiology, Faculty of Medicine, University of Tabuk, Tabuk, Saudi Arabia; 4. Department of Family and Community Medicine, Faculty of Medicine, University of Tabuk, Tabuk, Saudi Arabia; 5. Department of Experimental Medicine, King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Ministry of National Guard-Health Affairs (MNGHA), Riyadh, Saudi Arabia; 6. Forensic Toxicology Services, Forensic Medical Services Center, Ministry of Health, Abha, Saudi Arabia; 7. Pharmaceutical Services Department, Security Forces Hospital, Riyadh, Saudi Arabia; 8. Forensic Medical Services Center, Tabuk Region, Ministry of Health, Tabuk, Saudi Arabia; 9. Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan; 10. Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt; 11. Department of Microbiology and Immunology, Faculty of Pharmacy, Assiut University, Assiut, EgyptShow moreShow less
Source PDF DOI Publisher page
74 days

Comparison of four breast lymphoedema patient reported outcome measures in women following breast conserving surgery and radiotherapy: examination of frequencies of symptoms and measurement properties

Authors
Nicola Fearn; Sharon Kilbreath; Elizabeth Dylke; Wei Wang; Catalina Llanos; Verity Ahern; Elisabeth Elder; Farid Meybodi; Nicholas Olsen; Kirsty StuartShow moreShow less
Affiliations
1. Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; 2. Westmead Breast Cancer Institute, Westmead Hospital, Sydney, Australia; 3. Sydney Medical School, The University of Sydney, Sydney, Australia; 4. Sydney West Radiation Oncology Network, Westmead Hospital, Sydney, Australia; 5. Stats Central, University of New South Wales, Sydney, AustraliaShow moreShow less
Source PDF DOI Publisher page
111 days

Target trial emulation of first-line ribociclib versus palbociclib in hormone receptor-positive, HER2-negative metastatic breast cancer: a comparative effectiveness study

Authors
Xiaoyi Zhang; Po-Huang Chen; Wei-Cheng Chang; Hong-Jie Jhou; Hsin-Yu Chen; Li-Ting Kao; Tina Yi-Jin Hsieh; Ming-Shen Dai; Na Xiao; Cho-Hao LeeShow moreShow less
Affiliations
1. Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, USA; 2. Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan; 3. Department of Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan; 4. Department of Ophthalmology, Universe Eye Center, Taipei, Taiwan; 5. Neurological Institute, Changhua Christian Hospital, Changhua, Taiwan; 6. Department of Family Medicine, Chi Mei Medical Center, Tainan, Taiwan; 7. Graduate Institute of Life Sciences, National Defense Medical University, Taipei, Taiwan; 8. School of Pharmacy, National Defense Medical University, Taipei, Taiwan; 9. Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, USA; 10. Cheeloo College of Medicine, Shandong University, Jinan, ChinaShow moreShow less
Source PDF DOI Publisher page
74 days

Preoperative CA15-3 as a predictor of axillary lymph node metastasis and prognosis in women with breast cancer: a GRADE-assessed systematic review and meta-analysis

Authors
Mansour Bahardoust; Anita Rezaei; Anahita Hosseinali; Golnaz Ranjbarpazuki; Sajad Salehi; Meisam Haghmoradi; Shoboo Rahmati; Nahid NafissiShow moreShow less
Affiliations
1. Breast Cancer Research Center, Iran University of Medical Sciences, Tehran, Iran; 2. School of Medicine, Iran University of Medical Sciences, Tehran, Iran; 3. Urmia University of Medical Sciences, Urmia, Iran; 4. Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, IranShow moreShow less
Source PDF DOI Publisher page
107 days

Effects of exercise and educational programs on long-term quality of life, anxiety, and depression in breast cancer survivors: an exploratory secondary analysis of the Setouchi breast project-10 randomized controlled trial

Authors
Azusa Jo; Takayuki Iwamoto; Kengo Kawada; Youko Suzuki; Kyoko Hara; Seiji Yoshitomi; Daisuke Takabatake; Shinichiro Kubo; Yutaka Ogasawara; Shozo Ohsumi; Masahiko Ikeda; Hiroyoshi Doihara; Yuri Mizota; Seiichiro Yamamoto; Naruto TairaShow moreShow less
Affiliations
1. Department of Breast and Thyroid Surgery, Kawasaki Medical School, Kurashiki, Japan; 2. Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan; 3. Kawada surgery and plastic surgery, Okayama, Japan; 4. Department of Breast and Endocrine Surgery, Japanese Red Cross Okayama Hospital, Okayama, Japan; 5. Department of Breast and Thyroid Surgery, Fukuyama City Hospital, Fukuyama, Japan; 6. Department of Breast and Endocrine Surgery, Kagawa Prefectural Central Hospital, Takamatsu, Japan; 7. Department of Breast Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan; 8. Department of Surgery, Kawasaki Medical School General Medical Center, Okayama, Japan; 9. Shizuoka Graduate University of Public Health, Nagaizumi-cho, JapanShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Breast Cancer take to review a manuscript?

As of 2026-11-19, CrushSCI has 22 complete review records for Breast Cancer. The fastest paper went from submission to acceptance in 27 days (Generalizability and reproducibility challenges in morphometric assessment of nuclear atypia in breast cancer, received 2026-06-16, accepted 2026-07-13); the slowest took 323 days. The average is 154.5 days and the median is 154.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.